Comparing Ergoteles LLC's 13F Holdings in Q3 and Q4 of 2022: A Comprehensive Analysis

Ergoteles LLC has recently released its 13F filings, indicating the firm's changes in holdings for Q3 and Q4 of 2022. In this blog post, we will take a closer look at the data provided and analyze the differences between the two quarters. While the 13F data may not provide a complete picture of the company's portfolio, it can help investors make informed decisions based on the current holdings of the fund.

Firstly, it is essential to understand the 13F filings' purpose and limitations. The Securities and Exchange Commission (SEC) requires institutional investment managers with assets over $100 million to file their holdings quarterly on form 13F. However, it is worth noting that 13F filings do not disclose short positions and should not be used as a sole basis for investment decisions.

Looking at Ergoteles LLC's Q3 and Q4 holdings, we can see that the company added some new positions, completely sold out of a few others, and increased or decreased its stake in numerous holdings. One of the most significant changes occurred in the company's holdings of MPC (Marathon Pete Corp), where the fund increased its shares by approximately 14%. The value of these shares increased by about 34%, making it one of the most significant holdings of the company in Q4.

Another substantial change occurred in Ergoteles LLC's holdings of Stor Cap Corp (STOR), where the company increased its shares by approximately 506%. The value of these shares also increased significantly by approximately 519%. This is another critical holding for the company in Q4, reflecting the fund's confidence in the company's future prospects.

The company also revealed a few new positions, such as Signify Health Inc (SGFY) and Imago Biosciences Inc. However, in Q4, Ergoteles LLC sold out of its holdings in Comcast Corp New (CMCSA) and Clorox Co Del (CLX). It is worth noting that these data points do not represent absolute increases or decreases in investments. Still, rather relative changes between two reporting periods that help to identify new companies, stock sales, or shifting portfolio priorities.

In conclusion, analyzing Ergoteles LLC's Q3 and Q4 13F filings sheds some light on their portfolio changes between the two quarters. While 13F filings have their limitations, they can provide investors with valuable insights into institutional investors' investment strategies. It is essential to remember that a 13F filing represents a snapshot of a point in time and that investments carry risk, and investors should always do their own due diligence.